Skip to content

Cardinal Health CAH Indefinite-Lived Intangible Assets

Indefinite-Lived Intangible Assets at other companies

AbbVie logo
AbbVieABBV
$5.27B-0.4%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.75B+36.8%
Enterprise value$59.73B+30.8%
P/E35.2×+9.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's indefinite-lived intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's indefinite-lived intangible assets?
Cardinal Health (CAH) reported indefinite-lived intangible assets of $25M in Q1 2026.
How has Cardinal Health's indefinite-lived intangible assets changed year-over-year?
Cardinal Health's indefinite-lived intangible assets increased by 92.3% year-over-year, from $13M to $25M.
What is the long-term trend for Cardinal Health's indefinite-lived intangible assets?
Over 4 years (2021 to 2025), Cardinal Health's indefinite-lived intangible assets has grown at a 2.0% compound annual growth rate (CAGR), from $12M to $13M.
What does indefinite-lived intangible assets mean?
This represents intangible assets, such as iconic brand names or trademarks, that are expected to generate cash flows for an unlimited period. Unlike finite-lived assets, these are not amortized but are tested annually for impairment. They represent the core long-term value of the company's brand portfolio.